Characteristics of COVID-19 and Impact of Disease Activity in Patients with Adult-Onset Still's Disease.

Xinyue HongXiaoming WangNingqi DaiYue SunHonglei LiuXiaobing ChengJunna YeHui ShiQiongyi HuJianfen MengZhuochao ZhouChengde YangJialin TengYutong SuHuihui Chi

Published in: Rheumatology and therapy (2024)

Patients with AOSD receiving medium or high-dose glucocorticoid therapy or JAK inhibitors had worse COVID-19 outcomes. Further work is needed to explore risk factors affecting COVID-19 outcomes and the impact of COVID-19 on disease activity in AOSD.

Keyphrases

disease activity
coronavirus disease
sars cov
systemic lupus erythematosus
rheumatoid arthritis
rheumatoid arthritis patients
ankylosing spondylitis
high dose
juvenile idiopathic arthritis
respiratory syndrome coronavirus
stem cells
replacement therapy